Skip to content

Influence of intraoperative intravenous infusion lidocaine on post laparoscopic shoulder pain after gynecological laparoscopic surgery: a randomized controlled trial.

Influence of intraoperative intravenous infusion lidocaine on post laparoscopic shoulder pain after gynecological laparoscopic surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100041661
Enrollment
Unknown
Registered
2021-01-01
Start date
2020-12-28
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post laparoscopic shoulder pain

Interventions

Saline control group:intravenous infusion NS

Sponsors

Guangdong Provincial Hospital of Tradition Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for elective gynecological laparoscopic surgery under general anesthesia with endotracheal intubation; 2. Patients aged 18-70 years old; 3. Patients who voluntarily participated in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with body weight less than 35kg; 2. Subjects with ASA grade >= 3; 3. Patients with liver cirrhosis and severe chronic renal impairment; 4. Pregnant women; 5. Patients with severe arrhythmia; 6. Patients with congestive heart failure; 7. Epileptic patients; 8. Patients allergic to the study drug; 9. Patients with chronic shoulder pain for more than 2 months; 10. Patients with limited self-expression; 11. Patients with visual impairment; 12. Patients with severe mental illness.

Design outcomes

Primary

MeasureTime frame
incidence of post laparoscopic shoulder pain;

Countries

China

Contacts

Public ContactDanyang Pan

Guangdong Hospital of traditional Chinese Medicine

718991015@qq.com+86 13246886285

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026